An Open-labeled Pilot Study to Determine the Efficacy of an E2//Nomegestrol Acetate (E2/NOMAC)Combination Oral Contraceptive (COC) in the Management of Heavy Menstrual Bleeding (HMB)

Trial Profile

An Open-labeled Pilot Study to Determine the Efficacy of an E2//Nomegestrol Acetate (E2/NOMAC)Combination Oral Contraceptive (COC) in the Management of Heavy Menstrual Bleeding (HMB)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Estradiol/nomegestrol (Primary)
  • Indications Menorrhagia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Nov 2014 Planned End Date changed from 1 Dec 2013 to 1 Aug 2015, according to ClinicalTrials.gov record.
    • 18 Nov 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Apr 2015, according to ClinicalTrials.gov record.
    • 18 Nov 2014 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top